Nuvation Bio NUVB
NYSE NUVB
$4.21 -0.14 (-3.22%)
As of: Nov 10, 2026 · 3:59 PM EST

Nuvation Bio (NUVB) Debt Ratio (2020 - 2026)

Updated

Nuvation Bio's Debt Ratio came in at 0.01 for Q2 2026, down 90.3% from 0.08 a year earlier and down 90.9% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Debt Ratio (2020 - 2026) Analysis & Trends

For FY2025, Nuvation Bio's Debt Ratio was 0.09, up 665.7% from FY2024.

  • Going back by year, Debt Ratio was 0.01 in FY2024.
  • The Q2 2026 figure represents the lowest quarterly Debt Ratio in data going back to Q2 2020.
  • Year-over-year, Debt Ratio increased in four of the last five quarters, with growth averaging 407.8%.
  • Business Quant data shows NUVB's Debt Ratio at 0.09 (Q1 2026), 0.09 (Q4 2025) and 0.09 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Nuvation Bio 1.51 Bn -881.30 Mn - 0.01
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 0.01
Jun 30, 2026 0.01
Mar 31, 2026 0.09
Dec 31, 2025 0.09
Sep 30, 2025 0.09
Jun 30, 2025 0.08
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.02
Jun 30, 2020 0.47
API Access

Nuvation Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NUVB&period=max&api_key=YOUR_API_KEY